Frequently Asked Questions

Question 1

What is Bulkamid and what is it used for?

Accepted Answer

Bulkamid is an FDA-approved soft hydrogel composed of 97.5% water and 2.5% cross-linked polyacrylamide polymer. Doctors inject it into the tissue around the urethra to treat stress urinary incontinence (SUI) by restoring volume to the urethral wall and improving its ability to seal shut during physical activity.

Question 2

How long does the Bulkamid procedure take?

Accepted Answer

The actual injection procedure takes approximately 10 minutes and is typically performed in an office or outpatient procedure room under local anesthesia. Total visit time, including preparation and post-procedure observation, is usually 60 to 90 minutes, and most patients are discharged the same day.

Question 3

Is Bulkamid permanent, and will I need repeat injections?

Accepted Answer

Bulkamid is a non-resorbable gel, meaning the body does not break it down over time, which distinguishes it from earlier bulking agents like collagen that required frequent repeat injections. Most patients experience sustained benefit without needing additional treatment, although a touch-up injection is an option years later if needed.

Question 4

How effective is Bulkamid compared to a midurethral sling?

Accepted Answer

Midurethral sling surgery demonstrates cure or improvement rates of 80 to 90% and is generally more effective for severe SUI. Bulkamid delivers significant symptom improvement in the majority of appropriately selected patients with mild to moderate SUI, without surgery, mesh, general anesthesia, or extended recovery. The best choice depends on symptom severity, anatomy, and patient preference.

Question 5

What are the side effects and risks of Bulkamid?

Accepted Answer

The most common side effects include injection site pain (reported in approximately 12% of patients in the FDA trial), temporary urinary urgency, and mild blood-tinged urine, all of which typically resolve within 24 to 72 hours. Temporary urinary retention is the most clinically significant early complication and is more common in office settings than surgical center settings, but it is manageable with catheterization and resolves without long-term consequences in most cases.

Question 6

Does Bulkamid contain mesh or synthetic implants?

Accepted Answer

No. Bulkamid contains no synthetic mesh, synthetic tape, or implanted foreign device. It is a biocompatible, water-based hydrogel, making it a mesh-free alternative to midurethral sling surgery for appropriately selected patients.

Question 7

Who is not a good candidate for Bulkamid?

Accepted Answer

Women with severe, high-volume stress urinary incontinence may achieve better outcomes with sling surgery. Those with active urinary tract infections, significant concurrent pelvic organ prolapse requiring surgical correction, or unrealistic expectations about achieving 100% dryness may not be ideal candidates. Candidacy requires a thorough evaluation including urodynamic testing.

Question 8

Can Bulkamid be used after a failed sling surgery?

Accepted Answer

Yes. A retrospective study reviewing outcomes in women treated with Bulkamid after sling revision for persistent SUI (2019 to 2024) found significant improvements in pad use and validated symptom scores even in this complex population. Bulkamid does not require anatomical conditions that a prior sling would compromise.

Question 9

How soon will I see results after a Bulkamid injection?

Accepted Answer

Most patients begin noticing symptom improvement within two to four weeks as the gel settles into position and the tissue adapts. Results typically stabilize by the second month following the procedure, and no ongoing maintenance or restrictions are required for the majority of patients.

Question 10

Is Bulkamid covered by insurance?

Accepted Answer

Insurance coverage for Bulkamid varies by plan and payer. Because Bulkamid is FDA-approved for a specific indication (SUI due to intrinsic sphincter deficiency), it may be eligible for coverage under many plans, particularly when conservative treatments have been documented as insufficient. A practice with dedicated insurance advocacy support can help navigate prior authorization and coverage questions on your behalf.

Question 11

What is the difference between Bulkamid and Botox for bladder issues?

Accepted Answer

Bulkamid is injected into the urethral wall tissue to treat stress urinary incontinence by adding volume and improving urethral closure. Botox for bladder issues is injected into the bladder muscle itself to treat overactive bladder and urgency urinary incontinence by temporarily reducing involuntary bladder contractions. These are different treatments for different types of incontinence and are not interchangeable.

Question 12

Can Bulkamid be combined with other pelvic health treatments?

Accepted Answer

Yes. Bulkamid can be coordinated with complementary treatments including pelvic floor physical therapy, hormone optimization, CO2 laser vaginal rejuvenation, radiofrequency treatments, and PRP therapies in a phased approach. The minimally invasive nature of Bulkamid and its brief recovery period make it compatible with concurrent or sequential treatment planning for related pelvic health concerns.

The Practice Healthcare

Latest from The Practice Healthcare

Bulkamid Injections for Stress Urinary Incontinence: The Complete Patient Guide

Breast Revision Surgery: The Complete Guide to Implant Revision, Recovery, and Long-Term Results

The Practice Healthcare

Latest from The Practice Healthcare

Bulkamid Injections for Stress Urinary Incontinence: The Complete Patient Guide

Breast Revision Surgery: The Complete Guide to Implant Revision, Recovery, and Long-Term Results

Ask about our new insurance coverage

Surgical Consultation

Medspa & Wellness Treatments

Women’s Health Appointment

Medspa Treatment Options